J
Juan Carlos Caicedo
Researcher at University of Valle
Publications - 128
Citations - 3453
Juan Carlos Caicedo is an academic researcher from University of Valle. The author has contributed to research in topics: Sputter deposition & Bilayer. The author has an hindex of 31, co-authored 118 publications receiving 2763 citations. Previous affiliations of Juan Carlos Caicedo include Universidad Autónoma de Occidente & Children's Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis.
Colleen L. Jay,Vadim Lyuksemburg,Daniela P. Ladner,Edward Wang,Juan Carlos Caicedo,Jane L. Holl,Michael Abecassis,Anton I. Skaro +7 more
TL;DR: Donation after cardiac death liver transplantation is marred by inferior outcomes including higher rates of biliary complications and ischemic cholangiopathy as well as increased mortality and graft failure.
Journal ArticleDOI
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy
Michael Vouche,Ali Habib,Thomas J. Ward,Edward Kim,Laura Kulik,Daniel Ganger,Mary F. Mulcahy,Talia Baker,Michael Abecassis,Kent T. Sato,Juan Carlos Caicedo,Jonathan P. Fryer,Ryan Hickey,Elias Hohlastos,Robert J. Lewandowski,Riad Salem +15 more
TL;DR: Radiation segmentectomy is an effective technique with a favorable risk profile and radiology‐pathology outcomes for solitary HCC ≤5 cm, and this approach may allow for treatment of HCC in difficult locations.
Journal ArticleDOI
Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
Michael Vouche,Robert J. Lewandowski,Rohi Atassi,Khairuddin Memon,Vanessa L. Gates,Robert K. Ryu,Ron C. Gaba,Mary F. Mulcahy,Talia Baker,Kent T. Sato,Ryan Hickey,Daniel Ganger,Ahsun Riaz,Jonathan P. Fryer,Juan Carlos Caicedo,Michael Abecassis,Laura Kulik,Riad Salem +17 more
TL;DR: Radiation lobectomy by Y90 is a safe and effective technique to hypertrophy the FLR while the right lobe tumor is treated synchronously and is of particular interest in the bridge-to-resection setting.
Journal ArticleDOI
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem,Ahmed Gabr,Ahsun Riaz,R. Mora,R. Ali,Michael Abecassis,Ryan Hickey,Laura Kulik,Daniel Ganger,Steven L. Flamm,Rohi Atassi,Bassel Atassi,Kent T. Sato,Al B. Benson,Mary F. Mulcahy,N. Abouchaleh,Ali Al Asadi,Kush R. Desai,Bartley Thornburg,Michael Vouche,Ali Habib,Juan Carlos Caicedo,Frank H. Miller,Vahid Yaghmai,Joseph Ralph Kallini,Samdeep K. Mouli,Robert J. Lewandowski +26 more
TL;DR: Based on the experience with 1,000 patients over 15 years, TARE is made a decision to adopt as the first‐line transarterial LRT for patients with HCC.
Journal ArticleDOI
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
Robert J. Lewandowski,Ahmed Gabr,N. Abouchaleh,R. Ali,Ali Al Asadi,R. Mora,Laura Kulik,Daniel Ganger,Kush R. Desai,Bartley Thornburg,Samdeep K. Mouli,Ryan Hickey,Juan Carlos Caicedo,Michael Abecassis,Ahsun Riaz,Riad Salem +15 more
TL;DR: RS provides response rates, tumor control, and survival outcomes comparable to curative-intent treatments for selected patients with early-stage HCC who have preserved liver function.